NDH.com

icon


Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications
orange bar


   Web Toolkit
   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Nursing Links

   CE

   Career Opportunities

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



levofloxacin
Levaquin Pharmaceutical company:
Ortho-McNeil Pharmaceutical Co.
www.ortho-mcneil.com

NEW INDICATION & DOSAGE
Treatment of complicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae or Proteus mirabilis, and acute pyelonephritis caused by E. coli--
Adults: 750 mg/day P.O. or I.V. for 5 days.
ADJUST-A-DOSE:
For patients with renal impairment--for creatinine clearance of 20 to 49 ml/minute, give 750 mg P.O. or I.V. every 48 hours; for creatinine clearance of 10 to 19 ml/minute and for patients on peritoneal dialysis or hemodialysis, give 750 mg initial dose P.O. or I.V., and then 500 mg every 48 hours.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins